Hydroxychloroquine use is not associated with QTc length in a large cohort of SLE and RA patients is a research paper published in Arthritis Research & Therapy (2021). On theSindex it has a DataRank of 0. It has been cited 37 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
national institute of arthritis and musculoskeletal and skin diseases
Grant: R01 AR050026
national institute of arthritis and musculoskeletal and skin diseases
Grant: U01 AR068043
National Institutes of Health
Grant: 3U01AR068043-04S1
Treatments Against RA and Effect on FDG PET CT:The TARGET Trial
National Institutes of Health
Grant: 2R01AR050026-12A1
Inflammation and Cardiovascular Disease in Rheumatoid Arthritis
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Hydroxychloroquine use is not associated with QTc length in a large cohort of SLE and RA patients
Additional file 1 of Hydroxychloroquine use is not associated with QTc length in a large cohort of SLE and RA patients
Hydroxychloroquine use is not associated with QTc length in a large cohort of SLE and RA patients
Hydroxychloroquine use is not associated with QTc length in a large cohort of SLE and RA patients